Mitoxantrone Analogues as Ligands for a Stem−Loop Structure of Tau Pre-mRNA

Journal of Medicinal Chemistry
2009.0

Abstract

A series of mitoxantrone (MTX) analogues have been designed, synthesized, and evaluated for binding to and stabilizing a stem-loop structure that serves as a splicing regulatory element in the pre-mRNA of tau, which is involved in Alzheimer's and other neurodegenerative diseases. Several compounds showed significantly improved binding activity relative to the original screening hit mitoxantrone. These findings establish essential structure-activity relationships to further optimize the activity of this promising class of compounds.

Knowledge Graph

Similar Paper

Mitoxantrone Analogues as Ligands for a Stem−Loop Structure of Tau Pre-mRNA
Journal of Medicinal Chemistry 2009.0
Discovery of benzimidazole derivatives as modulators of mitochondrial function: A potential treatment for Alzheimer's disease
European Journal of Medicinal Chemistry 2017.0
Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer’s and Other Neurodegenerative Diseases
Journal of Medicinal Chemistry 2017.0
Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies
Journal of Medicinal Chemistry 2014.0
Synthesis and evaluation of 1,2,3,4-tetrahydro-1-acridone analogues as potential dual inhibitors for amyloid-beta and tau aggregation
Bioorganic & Medicinal Chemistry 2018.0
Synthesis and evaluation of oxime derivatives as modulators for amyloid beta-induced mitochondrial dysfunction
European Journal of Medicinal Chemistry 2013.0
Design, synthesis and biological evaluation of 2-styryl-5-hydroxy-4-pyrone derivatives and analogues as multiple functional agents with the potential for the treatment of Alzheimer’s disease
Bioorganic & Medicinal Chemistry 2021.0
Analogs of methotrexate
Journal of Medicinal Chemistry 1979.0
Preparation and antitumor activity of additional mitomycin A analogs
Journal of Medicinal Chemistry 1989.0
Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects
Journal of Medicinal Chemistry 2014.0